GP with an interest in women’s health Dr Laura Patterson discusses key issues in identifying and managing symptoms of ...

Iovance stock drops 90% despite historic approval for Amtagvi. Click here for a full investment analysis of IOVA stock.

In a sold-out, black-tie event, Wellstar Foundation raised $1.25 million to support innovation and advancement across ...

Approval based on AEGEAN Phase III trial results which showed a 32% reduction in the risk of recurrence, progression or death vs. neoadjuvant chemotherapy alone ...